Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly Topotecan With Bevacizumab in Platinum Resistant Recurrent Ovarian Cancer
NCT00343044Phase 2Completed
- Sponsor
- Benaroya Research Institute
- Start
- Jun 2006
- Primary completion
- Jan 2010
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in ovarian cancer, fallopian tube cancer (PFTC), primary peritoneal cancer (PPC), sponsored by Benaroya Research Institute. Started Jun 2006; status: completed.
02
Drugs
bevacizumab
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT00343044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00343044.